SAN DIEGO (AP) _ Oncternal Therapeutics, Inc. (ONCT) on Thursday reported a loss of $7.7 million in its second quarter.

The San Diego-based company said it had a loss of 16 cents per share.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.

The biopharmaceutical company posted revenue of $883,000 in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $1.1 million.

In the final minutes of trading on Thursday, the company's shares hit $3.89. A year ago, they were trading at $2.95.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ONCT at https://www.zacks.com/ap/ONCT

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News